Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 74
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype

Oral microbiome and nitric oxide biomarkers in older pe...

 72

Metabolite regulation of epigenetics in cancer

Metabolite regulation of epigenetics in cancer

 93

Dysfunctional mitochondria trap proteins in the intermembrane space

Dysfunctional mitochondria trap proteins in the interme...

 93